opc 4392 has been researched along with 1,3-ditolylguanidine in 1 studies
| Studies (opc 4392) | Trials (opc 4392) | Recent Studies (post-2010) (opc 4392) | Studies (1,3-ditolylguanidine) | Trials (1,3-ditolylguanidine) | Recent Studies (post-2010) (1,3-ditolylguanidine) |
|---|---|---|---|---|---|
| 16 | 1 | 0 | 357 | 0 | 71 |
| Protein | Taxonomy | opc 4392 (IC50) | 1,3-ditolylguanidine (IC50) |
|---|---|---|---|
| polyadenylate-binding protein 1 | Homo sapiens (human) | 19.8 | |
| Rev | Human immunodeficiency virus 1 | 8.312 | |
| Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | 5.205 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.036 | |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | 0.1816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, T; Kurahashi, N; Miwa, T; Nishi, T; Oshiro, Y; Sakurai, Y; Sato, S; Tanaka, T; Tottori, K; Uwahodo, Y | 1 |
1 other study(ies) available for opc 4392 and 1,3-ditolylguanidine
| Article | Year |
|---|---|
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
Topics: Animals; Antidepressive Agents; Brain Concussion; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, sigma; Structure-Activity Relationship | 2000 |